2022
DOI: 10.1016/j.radonc.2022.04.015
|View full text |Cite
|
Sign up to set email alerts
|

Clinical evaluation of a deep learning model for segmentation of target volumes in breast cancer radiotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 28 publications
(27 reference statements)
0
6
0
Order By: Relevance
“… 43 Additionally, there is a need for standardised validation metrics to evaluate clinical acceptability and commissioning of AS models. 44 The CDV measures used in this study indicate AS variations in the x, y, and z axes, highlighting the importance of modifications based on clinical relevance. The software solution used for data processing was validated against a digital phantom through IBSI international collaboration.…”
Section: Discussionmentioning
confidence: 85%
“… 43 Additionally, there is a need for standardised validation metrics to evaluate clinical acceptability and commissioning of AS models. 44 The CDV measures used in this study indicate AS variations in the x, y, and z axes, highlighting the importance of modifications based on clinical relevance. The software solution used for data processing was validated against a digital phantom through IBSI international collaboration.…”
Section: Discussionmentioning
confidence: 85%
“…Performance was comparable between CTV right and left breast in studies that reported CTV performance in both breasts. 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 Dai et al performed a multi-institutional study that reported better performance for DLAS models on planning CT scans compared with scanning CT scans. 21 Lymph node CTVs are the most difficult fields for DLAS models.…”
Section: Resultsmentioning
confidence: 99%
“…Studies reported worse DLAS performance for CTV internal mammary lymph nodes (DSC, 0.51-0.60) and Rotter's space (DSC, 0.63). 23 , 24 Choi et al reported on several different lymph node levels with the lowest DLAS model performance for ESTRO guideline left CTV supraclavicular nodes (DSC, 0.7). 18 Almberg et al reported worst DLAS model performance for CTV interpectoral lymph nodes (DSC, 0.7).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Our results are consistent with other previous studies addressing this same topic. 6 , 18 , 19 We must mention that no lymphatic pathway contours were considered in this segment, due to technical reasons. The software version available at the moment of the study counted with the American Society for Radiation Oncology templates, while our contours are routinely performed according to the European Society for Radiotherapy and Oncology recommendations.…”
Section: Discussionmentioning
confidence: 99%